10-Q Filing

CENCORA, INC. CIK: 1140859 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001140859-20-000035`
Period End Date	20200630
Filing Date	20200805
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	abc-20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 90 Cash Flow Statement 84 Stockholders Equity 52 Comprehensive Income 28

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Allowances for returns and doubtful accounts	`AllowancesForReturnsAndDoubtfulAccounts`	$1.43B	USD	Point-in-time
Allowances for returns and doubtful accounts	`AllowancesForReturnsAndDoubtfulAccounts`	$1.22B	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.42B	USD	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.00B	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.49B	USD	Point-in-time
Cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Accounts receivable, less allowances for returns and doubtful accounts: $1,432,528 as of June 30, 2020 and $1,222,906 as of September 30, 2019	`AccountsReceivableNetCurrent`	$12.39B	USD	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	287.52M	shares	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	285.30M	shares	Point-in-time
Accounts receivable, less allowances for returns and doubtful accounts: $1,432,528 as of June 30, 2020 and $1,222,906 as of September 30, 2019	`AccountsReceivableNetCurrent`	$12.55B	USD	Point-in-time
Inventories	`InventoryNet`	$11.06B	USD	Point-in-time
Inventories	`InventoryNet`	$11.85B	USD	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	203.96M	shares	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	206.76M	shares	Point-in-time
Right to recover asset	`ContractWithCustomerAssetGrossCurrent`	$1.15B	USD	Point-in-time
Right to recover asset	`ContractWithCustomerAssetGrossCurrent`	$1.34B	USD	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	78.53M	shares	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	83.56M	shares	Point-in-time
Income tax receivable (Note 4)	`IncomeTaxesReceivable`	$5.86M	USD	Point-in-time
Income tax receivable (Note 4)	`IncomeTaxesReceivable`	$596.02M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$157.38M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$163.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$29.92B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$28.13B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.46B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.77B	USD	Point-in-time
Goodwill	`Goodwill`	$6.71B	USD	Point-in-time
Goodwill	`Goodwill`	$6.71B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.29B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$1.91B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$800.45M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$269.07M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$40.79B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$39.17B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$29.15B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$28.39B	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$966.71M	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$1.06B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$139.01M	USD	Point-in-time
Short-term debt	`DebtCurrent`	$519.71M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$29.58B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$30.63B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$4.03B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$3.62B	USD	Point-in-time
Long-term financing obligation (Note 1)	`FinanceObligation`	-	USD	Point-in-time
Long-term financing obligation (Note 1)	`FinanceObligation`	$320.52M	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$268.52M	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$284.07M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$1.81B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$1.86B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$494.76M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$98.81M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value - authorized, issued, and outstanding: 600,000,000 shares, 287,524,077 shares, and 203,961,405 shares as of June 30, 2020, respectively, and 600,000,000 shares, 285,295,170 shares, and 206,760,654 shares as of September 30, 2019, respectively	`CommonStockValue`	$2.88M	USD	Point-in-time
Common stock, $0.01 par value - authorized, issued, and outstanding: 600,000,000 shares, 287,524,077 shares, and 203,961,405 shares as of June 30, 2020, respectively, and 600,000,000 shares, 285,295,170 shares, and 206,760,654 shares as of September 30, 2019, respectively	`CommonStockValue`	$2.85M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.04B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$4.85B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.45B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.24B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-111.97M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-128.66M	USD	Point-in-time
Treasury stock, at cost: 83,562,672 shares as of June 30, 2020 and 78,534,516 shares as of September 30, 2019	`TreasuryStockValue`	$6.10B	USD	Point-in-time
Treasury stock, at cost: 83,562,672 shares as of June 30, 2020 and 78,534,516 shares as of September 30, 2019	`TreasuryStockValue`	$6.51B	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' equity	`StockholdersEquity`	$2.88B	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' equity	`StockholdersEquity`	$3.86B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$110.70M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$114.29M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.05B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.04B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.97B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.11B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.71B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$40.79B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$39.17B	USD	Point-in-time

Income Statement 90 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$45.37B	USD	1 Quarter
Revenue	`Revenues`	$140.65B	USD	3 Qtrs
Revenue	`Revenues`	$133.95B	USD	3 Qtrs
Revenue	`Revenues`	$45.24B	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$44.01B	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$136.80B	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsAndServicesSold`	$130.00B	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsAndServicesSold`	$44.14B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.23B	USD	1 Quarter
Gross profit	`GrossProfit`	$3.95B	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.23B	USD	1 Quarter
Gross profit	`GrossProfit`	$3.85B	USD	3 Qtrs
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.94B	USD	3 Qtrs
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$666.88M	USD	1 Quarter
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$2.05B	USD	3 Qtrs
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$656.94M	USD	1 Quarter
Depreciation	`DepreciationNonproduction`	$208.63M	USD	3 Qtrs
Depreciation	`DepreciationNonproduction`	$71.72M	USD	1 Quarter
Depreciation	`DepreciationNonproduction`	$69.59M	USD	1 Quarter
Depreciation	`DepreciationNonproduction`	$222.30M	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$131.56M	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$35.88M	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$85.09M	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$25.82M	USD	1 Quarter
Employee severance, litigation, and other	`RestructuringCharges`	$156.07M	USD	3 Qtrs
Employee severance, litigation, and other	`RestructuringCharges`	$165.63M	USD	3 Qtrs
Employee severance, litigation, and other	`RestructuringCharges`	$60.01M	USD	1 Quarter
Employee severance, litigation, and other	`RestructuringCharges`	$58.59M	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$570.00M	USD	3 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$361.65M	USD	3 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$977.78M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$932.08M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$406.69M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$404.83M	USD	1 Quarter
Other loss (income), net	`NonoperatingIncomeExpense`	$11.74M	USD	3 Qtrs
Other loss (income), net	`NonoperatingIncomeExpense`	$342.00K	USD	1 Quarter
Other loss (income), net	`NonoperatingIncomeExpense`	$-1.07M	USD	1 Quarter
Other loss (income), net	`NonoperatingIncomeExpense`	$-2.81M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-37.75M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-121.37M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-35.92M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-103.18M	USD	3 Qtrs
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	3 Qtrs
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	1 Quarter
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$371.12M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$343.83M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$822.46M	USD	3 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$849.63M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$56.57M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$100.63M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-595.32M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$69.11M	USD	1 Quarter
Net income	`ProfitLoss`	$721.83M	USD	3 Qtrs
Net income	`ProfitLoss`	$1.44B	USD	3 Qtrs
Net income	`ProfitLoss`	$287.27M	USD	1 Quarter
Net income	`ProfitLoss`	$302.00M	USD	1 Quarter
Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-918.00K	USD	3 Qtrs
Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.59M	USD	3 Qtrs
Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.17M	USD	1 Quarter
Net loss (income) attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$43.00K	USD	1 Quarter
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$1.44B	USD	3 Qtrs
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$722.75M	USD	3 Qtrs
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$289.44M	USD	1 Quarter
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$301.96M	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$1.44	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$1.42	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$3.45	USD	3 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$7.01	USD	3 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$6.95	USD	3 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$3.42	USD	3 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$1.43	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$1.41	USD	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	205.02M	shares	3 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	209.48M	shares	3 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	209.71M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	203.65M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	211.16M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	211.15M	shares	3 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	206.71M	shares	3 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	205.54M	shares	1 Quarter
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$1.24	USD	3 Qtrs
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.42	USD	1 Quarter
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.42	USD	Point-in-time
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.40	USD	1 Quarter
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$1.20	USD	3 Qtrs
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.40	USD	Point-in-time

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$721.83M	USD	3 Qtrs
Net income	`ProfitLoss`	$1.44B	USD	3 Qtrs
Net income	`ProfitLoss`	$287.27M	USD	1 Quarter
Net income	`ProfitLoss`	$302.00M	USD	1 Quarter
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$246.29M	USD	3 Qtrs
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$215.19M	USD	3 Qtrs
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$137.84M	USD	3 Qtrs
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$93.76M	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$15.04M	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$25.41M	USD	3 Qtrs
(Benefit) provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-7.20M	USD	3 Qtrs
(Benefit) provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$44.68M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$48.43M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$57.58M	USD	3 Qtrs
LIFO expense (credit)	`InventoryLIFOReservePeriodCharge`	$43.20M	USD	3 Qtrs
LIFO expense (credit)	`InventoryLIFOReservePeriodCharge`	$-79.75M	USD	3 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$570.00M	USD	3 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$361.65M	USD	3 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Gain on sale of an equity investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	3 Qtrs
Gain on sale of an equity investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$13.69M	USD	3 Qtrs
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	3 Qtrs
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	1 Quarter
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-10.24M	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$11.60M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$436.24M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$672.74M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$910.83M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$280.15M	USD	3 Qtrs
Income tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-522.00K	USD	3 Qtrs
Income tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$590.16M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.79M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-28.76M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$824.11M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$964.67M	USD	3 Qtrs
Accrued expenses, accrued income taxes, and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-274.78M	USD	3 Qtrs
Accrued expenses, accrued income taxes, and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-14.38M	USD	3 Qtrs
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$1.67B	USD	3 Qtrs
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$907.81M	USD	3 Qtrs
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$230.77M	USD	3 Qtrs
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$251.10M	USD	3 Qtrs
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$64.04M	USD	3 Qtrs
Cost of equity investments	`PaymentstoAcquireEquitySecuritiesFVNI`	-	USD	3 Qtrs
Cost of equity investments	`PaymentstoAcquireEquitySecuritiesFVNI`	$34.83M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-7.82M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$2.22M	USD	3 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-297.03M	USD	3 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-278.11M	USD	3 Qtrs
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$479.37M	USD	3 Qtrs
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$590.11M	USD	3 Qtrs
Senior notes and other loan repayments	`RepaymentsOfDebt`	$568.03M	USD	3 Qtrs
Senior notes and other loan repayments	`RepaymentsOfDebt`	$480.72M	USD	3 Qtrs
Borrowings under revolving and securitization credit facilities	`ProceedsFromLinesOfCredit`	$116.95M	USD	3 Qtrs
Borrowings under revolving and securitization credit facilities	`ProceedsFromLinesOfCredit`	$607.82M	USD	3 Qtrs
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$149.98M	USD	3 Qtrs
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$736.96M	USD	3 Qtrs
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	$21.45M	USD	3 Qtrs
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	-	USD	3 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$522.78M	USD	3 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$420.45M	USD	3 Qtrs
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$54.86M	USD	3 Qtrs
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$137.75M	USD	3 Qtrs
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$256.76M	USD	3 Qtrs
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$255.06M	USD	3 Qtrs
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$9.66M	USD	3 Qtrs
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$5.96M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.09M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-7.69M	USD	3 Qtrs
NET CASH USED IN FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$-583.62M	USD	3 Qtrs
NET CASH USED IN FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$-867.12M	USD	3 Qtrs
INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$507.04M	USD	3 Qtrs
INCREASE IN CASH AND CASH EQUIVALENTS	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$46.08M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.42B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.00B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.49B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.42B	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.00B	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.49B	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time

Stockholders Equity 52 line items

Line Item	Tag	Value	Unit	Period
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.20	USD	3 Qtrs
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.24	USD	3 Qtrs
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.42	USD	1 Quarter
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.40	USD	1 Quarter
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.05B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.04B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.97B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.11B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.71B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$721.83M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$1.44B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$287.27M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$302.00M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$2.49M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-1.12M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-4.97M	USD	3 Qtrs
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-27.88M	USD	3 Qtrs
Cash dividends	`DividendsCommonStockCash`	$86.22M	USD	1 Quarter
Cash dividends	`DividendsCommonStockCash`	$256.76M	USD	3 Qtrs
Cash dividends	`DividendsCommonStockCash`	$84.64M	USD	1 Quarter
Cash dividends	`DividendsCommonStockCash`	$255.06M	USD	3 Qtrs
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$17.27M	USD	1 Quarter
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$60.99M	USD	1 Quarter
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$137.75M	USD	3 Qtrs
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$54.86M	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.56M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$48.43M	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.82M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$57.58M	USD	3 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$498.89M	USD	3 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$13.30M	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$174.91M	USD	1 Quarter
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$405.69M	USD	3 Qtrs
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$292.00K	USD	1 Quarter
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$9.66M	USD	3 Qtrs
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$5.96M	USD	3 Qtrs
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$75.00K	USD	1 Quarter
Other	`StockholdersEquityOther`	$133.00K	USD	1 Quarter
Other	`StockholdersEquityOther`	$3.00K	USD	1 Quarter
Other	`StockholdersEquityOther`	$671.00K	USD	3 Qtrs
Other	`StockholdersEquityOther`	$418.00K	USD	3 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.05B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.04B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.97B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.11B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.71B	USD	Point-in-time
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.20	USD	3 Qtrs
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.24	USD	3 Qtrs
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.42	USD	1 Quarter
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.40	USD	1 Quarter

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$721.83M	USD	3 Qtrs
Net income	`ProfitLoss`	$1.44B	USD	3 Qtrs
Net income	`ProfitLoss`	$287.27M	USD	1 Quarter
Net income	`ProfitLoss`	$302.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.16M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-27.22M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.12M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$3.18M	USD	1 Quarter
Other	`OtherComprehensiveIncomeOtherNetOfTax`	$33.00K	USD	1 Quarter
Other	`OtherComprehensiveIncomeOtherNetOfTax`	$146.00K	USD	3 Qtrs
Other	`OtherComprehensiveIncomeOtherNetOfTax`	$-656.00K	USD	3 Qtrs
Other	`OtherComprehensiveIncomeOtherNetOfTax`	$-690.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$2.49M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.12M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-4.97M	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-27.88M	USD	3 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.42B	USD	3 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$716.86M	USD	3 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$289.76M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$300.88M	USD	1 Quarter
Comprehensive loss (income) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$1.74M	USD	3 Qtrs
Comprehensive loss (income) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-3.82M	USD	1 Quarter
Comprehensive loss (income) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-3.59M	USD	3 Qtrs
Comprehensive loss (income) attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$659.00K	USD	1 Quarter
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$715.12M	USD	3 Qtrs
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$300.22M	USD	1 Quarter
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$1.42B	USD	3 Qtrs
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$293.58M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.